186 related articles for article (PubMed ID: 16160866)
21. Regulation of mitofusin-2 expression in skeletal muscle.
Zorzano A
Appl Physiol Nutr Metab; 2009 Jun; 34(3):433-9. PubMed ID: 19448711
[TBL] [Abstract][Full Text] [Related]
22. Further lowering of muscle lipid oxidative capacity in obese subjects after biliopancreatic diversion.
Fabris R; Mingrone G; Milan G; Manco M; Granzotto M; Dalla Pozza A; Scarda A; Serra R; Greco AV; Federspil G; Vettor R
J Clin Endocrinol Metab; 2004 Apr; 89(4):1753-9. PubMed ID: 15070941
[TBL] [Abstract][Full Text] [Related]
23. Intramyocitic lipid accumulation and SREBP-1c expression are related to insulin resistance and cardiovascular risk in morbid obesity.
Mingrone G; Rosa G; Greco AV; Manco M; Vega N; Nanni G; Castagneto M; Vidal H
Atherosclerosis; 2003 Sep; 170(1):155-61. PubMed ID: 12957694
[TBL] [Abstract][Full Text] [Related]
24. Evidence for a mitochondrial regulatory pathway defined by peroxisome proliferator-activated receptor-gamma coactivator-1 alpha, estrogen-related receptor-alpha, and mitofusin 2.
Soriano FX; Liesa M; Bach D; Chan DC; Palacín M; Zorzano A
Diabetes; 2006 Jun; 55(6):1783-91. PubMed ID: 16731843
[TBL] [Abstract][Full Text] [Related]
25. Reduced PDK4 expression associates with increased insulin sensitivity in postobese patients.
Rosa G; Di Rocco P; Manco M; Greco AV; Castagneto M; Vidal H; Mingrone G
Obes Res; 2003 Feb; 11(2):176-82. PubMed ID: 12582211
[TBL] [Abstract][Full Text] [Related]
26. Preservation of skeletal muscle mitochondrial content in older adults: relationship between mitochondria, fibre type and high-intensity exercise training.
Wyckelsma VL; Levinger I; McKenna MJ; Formosa LE; Ryan MT; Petersen AC; Anderson MJ; Murphy RM
J Physiol; 2017 Jun; 595(11):3345-3359. PubMed ID: 28251664
[TBL] [Abstract][Full Text] [Related]
27. Diazoxide enhances basal metabolic rate and fat oxidation in obese Zucker rats.
Alemzadeh R; Karlstad MD; Tushaus K; Buchholz M
Metabolism; 2008 Nov; 57(11):1597-607. PubMed ID: 18940400
[TBL] [Abstract][Full Text] [Related]
28. Mitofusin 2 mutations affect mitochondrial function by mitochondrial DNA depletion.
Vielhaber S; Debska-Vielhaber G; Peeva V; Schoeler S; Kudin AP; Minin I; Schreiber S; Dengler R; Kollewe K; Zuschratter W; Kornblum C; Zsurka G; Kunz WS
Acta Neuropathol; 2013 Feb; 125(2):245-56. PubMed ID: 22926664
[TBL] [Abstract][Full Text] [Related]
29. Changes in FAT/CD36, UCP2, UCP3 and GLUT4 gene expression during lipid infusion in rat skeletal and heart muscle.
Vettor R; Fabris R; Serra R; Lombardi AM; Tonello C; Granzotto M; Marzolo MO; Carruba MO; Ricquier D; Federspil G; Nisoli E
Int J Obes Relat Metab Disord; 2002 Jun; 26(6):838-47. PubMed ID: 12037655
[TBL] [Abstract][Full Text] [Related]
30. Skeletal muscle mitochondria in insulin resistance: differences in intermyofibrillar versus subsarcolemmal subpopulations and relationship to metabolic flexibility.
Chomentowski P; Coen PM; Radiková Z; Goodpaster BH; Toledo FG
J Clin Endocrinol Metab; 2011 Feb; 96(2):494-503. PubMed ID: 21106709
[TBL] [Abstract][Full Text] [Related]
31. Insulin resistance in nondiabetic morbidly obese patients: effect of bariatric surgery.
Pereira JA; Lazarin MA; Pareja JC; de Souza A; Muscelli E
Obes Res; 2003 Dec; 11(12):1495-501. PubMed ID: 14694214
[TBL] [Abstract][Full Text] [Related]
32. Reversibility of insulin resistance in obese diabetic patients: role of plasma lipids.
Mingrone G; DeGaetano A; Greco AV; Capristo E; Benedetti G; Castagneto M; Gasbarrini G
Diabetologia; 1997 May; 40(5):599-605. PubMed ID: 9165230
[TBL] [Abstract][Full Text] [Related]
33. Dissociation of obesity and insulin resistance in transgenic mice with skeletal muscle expression of uncoupling protein 1.
Katterle Y; Keipert S; Hof J; Klaus S
Physiol Genomics; 2008 Feb; 32(3):352-9. PubMed ID: 18042832
[TBL] [Abstract][Full Text] [Related]
34. Overexpression of muscle uncoupling protein 2 content in human obesity associates with reduced skeletal muscle lipid utilization.
Simoneau JA; Kelley DE; Neverova M; Warden CH
FASEB J; 1998 Dec; 12(15):1739-45. PubMed ID: 9837864
[TBL] [Abstract][Full Text] [Related]
35. Effect of insulin on human skeletal muscle mitochondrial ATP production, protein synthesis, and mRNA transcripts.
Stump CS; Short KR; Bigelow ML; Schimke JM; Nair KS
Proc Natl Acad Sci U S A; 2003 Jun; 100(13):7996-8001. PubMed ID: 12808136
[TBL] [Abstract][Full Text] [Related]
36. Decreased muscle acetyl-coenzyme A carboxylase 2 mRNA and insulin resistance in formerly obese subjects.
Rosa G; Manco M; Vega N; Greco AV; Castagneto M; Vidal H; Mingrone G
Obes Res; 2003 Nov; 11(11):1306-12. PubMed ID: 14627750
[TBL] [Abstract][Full Text] [Related]
37. Increase in skeletal muscle fatty acid binding protein (FABPC) content is directly related to weight loss and to changes in fat oxidation following a very low calorie diet.
Blaak EE; Glatz JF; Saris WH
Diabetologia; 2001 Nov; 44(11):2013-7. PubMed ID: 11719832
[TBL] [Abstract][Full Text] [Related]
38. The Charcot-Marie-Tooth type 2A gene product, Mfn2, up-regulates fuel oxidation through expression of OXPHOS system.
Pich S; Bach D; Briones P; Liesa M; Camps M; Testar X; Palacín M; Zorzano A
Hum Mol Genet; 2005 Jun; 14(11):1405-15. PubMed ID: 15829499
[TBL] [Abstract][Full Text] [Related]
39. Slow component of [V]O(2) kinetics: the effect of training status, fibre type, UCP3 mRNA and citrate synthase activity.
Russell A; Wadley G; Snow R; Giacobino JP; Muzzin P; Garnham A; Cameron-Smith D
Int J Obes Relat Metab Disord; 2002 Feb; 26(2):157-64. PubMed ID: 11850746
[TBL] [Abstract][Full Text] [Related]
40. Changes in skeletal muscle mitochondria in response to the development of type 2 diabetes or prevention by daily wheel running in hyperphagic OLETF rats.
Rector RS; Uptergrove GM; Borengasser SJ; Mikus CR; Morris EM; Naples SP; Laye MJ; Laughlin MH; Booth FW; Ibdah JA; Thyfault JP
Am J Physiol Endocrinol Metab; 2010 Jun; 298(6):E1179-87. PubMed ID: 20233940
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
